Dr. Dirk Weber, Chief Medical Officer

Dr. Dirk Weber

Chief Medical Officer

Dirk is an MD, PhD with 12+ years of Pharma Industry experience in oncology drug development from global leadership positions (Merck, Novartis, Takeda). He has worked in early- and late-stage clinical development programs which included interactions with all major regulatory authorities, dossier filing and successful lead of submission teams. He also has extensive experience in conducting Medical Affairs activities to prepare markets for commercial launches. He has longstanding oncology drug development expertise with major brands (Afinitor, Patupilone, Sandostatin, Erbitux, Matuzumab, Adcetris, Ixazomib, Alisertib, Mepact). He has excellent regulatory filing and launch experience throughout career. His extended leadership experience he gained by leading clinical teams at Merck and Novartis as well as by leading the EM regional office of Takeda Oncology as Medical Director with managing the medical strategy of the oncology portfolio in 30+ Emerging Market countries. He is co-founder of Aurealis Pharma and Cellestia Biotech SA and represents both companies as Chief Medical Officer. Linkedin Profile


2015 – today
Cellestia Biotech AG, Basel, Switzerland (& Lausanne, Switzerland)
Chief Medical Officer (CMO) & co-founder

2012 – today
Aurealis Pharma AG, Basel, Switzerland ( & Kuopio, Finland)
Chief Medical Officer (CMO) & BOD member (co-founder)

2013 – 2015
Takeda Pharmaceuticals International GmbH, Zürich, Switzerland
Regional Medical Head (Emerging Markets)

2007 – 2013
Novartis Pharma AG, Basel, Switzerland
Global Clinical Program Head Oncology

2003 – 2007
Merck KGaA, Darmstadt, Germany (later Merck Serono AG) Global Clinical Team Leader & Medical Advisor Oncology

2001 – 2003
Ivonex GmbH, Kiel, Germany (Biotech start-up)
Group Leader Research & Development (R&D)

Department of Traumatology & Orthopedic Surgery, Lubinus Clinicum Kiel, Germany
MD residency

2000 – 2001
Institute of General Pathology and Pathological Anatomy, CAU Kiel, Germany
MD residency


1997 – 2001
MD PhD Thesis, - magna cum laude -, scholarship from Helmut Robert Foundation

  • Christian-Albrechts-University, Kiel, Germany
  • Lombardi Cancer Center, Washington DC, USA

1992 – 2000
Medical School, M.D. degree, Christian-Albrechts-University, Kiel, Germany

1994 – 1996
Medical School, ERASMUS program, University of Kuopio, Kuopio, Finland

1999 – 2000
Medical School, M.D. degree, Georgetown University, Washington DC, USA